Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using magnetic stimulation to reduce fatigue in multiple sclerosis

Official title: Neuromodulation of the Left Premotor Cortex With Transcranial Magnetic Stimulation to Alleviate Fatigue in Multiple Sclerosis - a Randomised Controlled Clinical Trial

Run by Danish Research Centre for Magnetic Resonance · NCT06569550 · Data updated 2026-11-12

This study is testing if a type of magnetic stimulation can help reduce fatigue in people with Relapsing-Remitting Multiple Sclerosis.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorDanish Research Centre for Magnetic Resonance
Academic / other
Locations1 site (Hvidovre, Capital Region)
StatusRecruiting
StartedAugust 14, 2024
Main results expectedJanuary 21, 2027
Study endsFebruary 21, 2027
Registry record updatedSeptember 22, 2026
Trial IDNCT06569550 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with Relapsing-Remitting Multiple Sclerosis who experience moderate to severe fatigue.

Probably not a fit

Patients with significant psychiatric disorders, recent MS relapses, or those currently receiving treatment for fatigue may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine if repetitive Transcranial Magnetic Stimulation (rTMS) of the left premotor cortex can alleviate fatigue in patients with Relapsing-Remitting Multiple Sclerosis. Participants will receive either real or sham rTMS for 30 minutes over five consecutive days, followed by assessments through questionnaires and brain scans to evaluate changes in fatigue levels and brain activity. The study seeks to understand the relationship between brain excitation and inhibition in relation to fatigue symptoms in these patients.

Why it matters

Potential benefit: If successful, this intervention could provide a new non-pharmacological treatment option for managing fatigue in patients with Multiple Sclerosis.

How similar studies have gone: While the approach of using rTMS for fatigue in MS is relatively novel, similar studies have shown promise in other neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* A confirmed diagnosis of relapse-remitting or secondary progressive multiple sclerosis, according to most recent McDonald's criteria (Thompson et al., 2018). This diagnosis must not be more recent than 3 months
* Must have fatigue as a complaint, and an FSMC score corresponding to at least moderate fatigue (\>53)
* Stable MS medication for at least 3 months

Exclusion Criteria:

* Pregnancy, any subject with the potential to become pregnant must ensure against this (e.g. by taking oral contraceptives, or other high efficacy method)
* MS Relapse or steroid treatment within 3 months prior to inclusion
* Current treatment targeted towards fatigue, or previous if discontinued within 3 months prior to inclusion
* History of neurologic disease or other significant medical conditions, aside from MS
* EDSS \> 6.5
* Major psychiatric disorder, including current clinical depression.
* Intake of medication that primarily acts on CNS or neurotransmission, except SSRI or SNRI
* Pacemaker or other implanted electronic devices
* Any intracranial metal
* Any metallic implant incompatible with MR scanning
* Claustrophobia
* Either patient or their close relatives suffering from epilepsy
* Current Drug or alcohol abuse

Where it's running

  • Danish Research Centre for Magnetic Resonance
    Hvidovre, Capital Region, Denmark
    Recruiting

Study contacts

  • Principal investigator: Hartwig R Siebner, MD, DMSc — Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre & University of Copenhagen
  • Study coordinator: Hartwig R Siebner, MD, DMSc
  • Email: hartwig@drcmr.dk
  • Phone: 3862 6541

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.